Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis

MLA

Chi‐Chao Chao, et al. “Diflunisal versus Tafamidis on Neuropathy and Cardiomyopathy in Hereditary Transthyretin Amyloidosis.” Annals of Clinical and Translational Neurology, vol. 11, no. 9, Sept. 2024, pp. 2426–38. EBSCOhost, https://doi.org/10.1002/acn3.52158.

APA

Chi‐Chao Chao, Shiou‐Ru Tzeng, Ming‐Chang Chiang, Hsueh‐Wen Hsueh, Wan‐Jen Hsieh, Yuan‐Chun Chao, Mei‐Fang Cheng, Yen‐Hung Lin, Mao‐Yuan Su, Chun‐Hsiang Huang, Yi‐Shiang Wang, Ming‐Fang Hsieh, Ping‐Huei Tseng, & Sung‐Tsang Hsieh. (2024). Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis. Annals of Clinical and Translational Neurology, 11(9), 2426–2438. https://doi.org/10.1002/acn3.52158

Chicago

Chi‐Chao Chao, Shiou‐Ru Tzeng, Ming‐Chang Chiang, Hsueh‐Wen Hsueh, Wan‐Jen Hsieh, Yuan‐Chun Chao, Mei‐Fang Cheng, et al. 2024. “Diflunisal versus Tafamidis on Neuropathy and Cardiomyopathy in Hereditary Transthyretin Amyloidosis.” Annals of Clinical and Translational Neurology 11 (9): 2426–38. doi:10.1002/acn3.52158.